2021 Physician Fee Schedule Changes
Courtney McKay, CPA - Partner - Consulting Services
Anna Brewer CVA - Partner - Consulting Services
Haley Adams, CVA - Sr. Manager - Consulting Services
The Centers for Medicare and Medicaid Services has made significant changes to Evaluation and Management CPT codes effective January 1, 2021. These changes are expected to have a significant impact on both physician practice revenue as well as physician compensation. The impact will vary based on specialty, payer mix, and other factors, but practice administrators and health systems that employ physicians should begin planning now to ensure they are prepared for the changes on the horizon.
Each year, the Centers for Medicare and Medicaid Services (“CMS”) reviews the listing of Current Procedural Terminology (“CPT”) codes that are used for billing professional medical services. Often, new codes are added to reflect new or modified services, or codes may be removed from the list if they are no longer deemed necessary. As part of this review process, CMS considers whether any changes should be made with regard to the Relative Value Units (“RVU”) associated with each CPT code, including the Work RVU (“wRVU”) component, which is intended to reflect the time and complexity to perform the service.
In 2017, CMS launched the “Patients over Paperwork” initiative, with the goal of eliminating unnecessary or burdensome regulations. The overarching objective of this initiative was to encourage innovation and allow providers to focus their efforts on meeting the needs of their patients. One component of this initiative was to study the appropriateness of the RVU values associated with new and established office visit CPT codes. This involved, among other things, a time study that indicated that providers are spending more time on each patient visit than they did a few years ago. The increase reflects a combination of increased time with the patient, time associated with required documentation in electronic medical record (“EMR”) systems, and time associated with coordinating care with other providers and/or managing chronic conditions.
Given the high frequency of office evaluation and management (“E&M”) visits, which CMS indicates account for around 20% of total allowed charges for physician services, any changes to wRVU values associated with these codes will have a significant impact on reimbursement for these professional services and potentially physician compensation, if all or part is based on productivity.
2021 E&M Changes
As a result of its in-depth assessment, CMS proposed significant changes to the office/outpatient E&M codes, which were finalized in the Calendar Year 2019 Physician Fee Schedule (“PFS”) Final Rule with an effective date of January 1, 2021. In connection with the increased wRVU values for each CPT code, CMS increased the total time attributed to each visit. The changes are summarized below:
As noted in the table above, CPT Code 99201 for a Level 1 new patient visit will be eliminated. Providers will select the appropriate CPT code based on either time or medical decision making, at the discretion of the provider. Additionally, a new code for prolonged visits (99XXX) will be added, which will be billed as an add-on to 99215 for extra 15-minute increments beyond the standard time for a 99215 visit. Finally, another new code (GPC1X) will be used to bill for visit complexity in applicable circumstances.
While the above codes have already been finalized by CMS for implementation in 2021, the 2021 PFS Proposed Rule released on August 4, 2020, includes additional proposed revisions to certain global CPT codes that include an expected number of office visits. Notably, this includes codes relating to maternity care, end-stage renal disease, and certain codes related to assessment and care planning for patients with cognitive impairment. Additionally, to retain alignment with outpatient E&M wRVU values, the 2021 PFS Proposed Rule includes recommended increases to Emergency Department E&M codes as well as therapy evaluation codes. These proposals must go through the comment period before being approved by CMS. The comment period closed October 5, 2020, and final determination regarding proposed changes to wRVU values for these services will be made in the 2021 PFS Final Rule, which is expected to be released in November or December prior to the January 1, 2021 effective date.
2021 Conversion Factor Changes
Medicare reimbursement for professional services is generally determined by multiplying the applicable RVU amounts for billed services by the conversion factor in place on the date the service was rendered (adjusted for the specific locality). In response to the significant increases to E&M wRVUs, the 2021 PFS Proposed Rule recommends reductions in both the Conversion Factor and the Anesthesia Conversion Factor, based on budget neutrality requirements. As a result, the proposed rates for 2021 are as follows:
This reduction will have a dramatic impact on all medical practices, though some specialties will be impacted more than others. For primary care and other specialties with a high number of office visits (such as endocrinology and rheumatology), the increase in E&M wRVUs may substantially offset the decreased Conversion Factor, depending upon practice patterns and payer mix. However, specialties that have a higher percentage of activity in procedural codes and fewer office visits will likely experience a significant decline in Medicare reimbursement, as the Conversion Factor will apply to all services billed, not just E&Ms.
Physician Compensation Considerations
Many employed physicians are compensated at least in part based on wRVU production. Given the substantial changes in wRVUs that will be effective in 2021, physician compensation will be directly impacted. For those specialties with high-volume office visits, volumes consistent with prior years will result in increased wRVUs, which could then substantially increase physician compensation depending on the structure of the compensation arrangement. Even without factoring in the decreased Conversion Factor, practices must consider whether the level of increase in compensation resulting from the revised wRVUs is warranted, and whether such amounts would be considered commercially reasonable in comparison to historical compensation levels and market benchmarks. Again, this issue is exacerbated by the reduced conversion factor that is expected to result in overall lower reimbursement for many specialties. Therefore, practices may be faced with increased compensation at the same time they experience reduced revenue for the same volume and mix of services as prior years. Unchecked, this could result in significant practice losses.
Consider the following example for a primary care physician:
As illustrated, the combination of decreased revenue and increased physician compensation can more than double the net loss for the practice. This dynamic is amplified even more for a specialty with a lower volume of office visits, as reflected in this example for orthopedic surgery:
In this case, the net loss is almost doubled from the prior year due to the combined impact of reduced revenue and increased physician compensation.
Historical reliance on market survey data was once the norm in determining compensation terms for physicians and evaluating fair market value. However, survey data is expected to be much less meaningful for the next several years. Surveys related to 2020 physician compensation and production will be impacted by changes in volume and service mix related to COVID-19 circumstances, such as the temporary closure of offices for some specialties, elimination of elective procedures for periods of time in many areas, and patients’ general reluctance to seek medical care for non-emergent issues during the pandemic for risk of exposure to the virus. In 2021, the data will be impacted by changes to the Medicare Physician Fee Schedule as wRVUs for such year will reflect the increases to the office E&M codes while collections will be impacted by the reduced Conversion Factor. In many cases, physician compensation will continue to reflect old compensation structures that do not fully contemplate the financial impact of the PFS changes as practices transition to new compensation structures over a period of time, perhaps as employment contracts come up for renewal. Accordingly, practices will need to use alternate methods of determining compensation terms that are fair market value and commercially reasonable until the market data stabilizes.
Physician practice organizations should create a task force to study the impact of wRVU and proposed Conversion Factor changes on the practice. This task force should likely include the following:
- Physician Organization Director;
- Chief Medical Officer or other physician leader; and
- Hospital and/or Practice Chief Financial Officer.
The task force should engage either internal or external resources to perform the following:
- Discretely calculate the expected wRVUs for each provider;
- Model the expected revenue impact, by provider, of the proposed changes;
- Model the expected physician compensation impact, based on current contract terms applicable to 2021; and
- Determine potential revisions to provider contracts that might be required to maintain commercial reasonability and/or financial feasibility for the practice.
It will be important to collaborate with legal counsel regarding any contemplated changes to physician compensation terms to ensure regulatory compliance. Organizations will need to develop a plan for communicating with providers and rolling out any necessary changes. Options may include:
- Immediate communication with providers regarding CMS changes and potential changes to provider compensation plans to be rolled out in 2021; or
- Communication with providers and associated changes to provider compensation terms as each contract comes up for renewal.
In addition to considering necessary changes to physician compensation terms, practices should also determine the potential impact for managed care payers. It will be important to identify which payer fee schedules are based on Medicare and develop a strategy for renegotiating contracts as deemed necessary to optimize the revenue stream for the practice.
JTaylor has a team of professionals dedicated to helping practices analyze the impact of these proposed changes. We can help you develop an effective strategy to mitigate the impact and ensure that your organization is positioned to be financially viable once the CMS changes are implemented.
 84 FR 62468
 85 FR 50074
- Stark Law and Anti-Kickback Statute Changes Released in Final Rules
- JTaylor’s Arielle Schmeck Recognized with AICPA Valuation “Standing Ovation”
- Hospital Pricing Transparency - Frequently Asked Questions (FAQs)
- FY 2021 Medicare Hospital IPPS and LTCH Final Rule: Changes effective October 1, 2020
- Provider Relief Fund Reporting Requirements: Updated Guidance Released by HHS
- CY 2021 Medicare Hospital OPPS & ASC Payment System Proposed Rule
- Healthcare Real Estate Outlook: How COVID-19 has changed the landscape
- Stark Law Updates Delayed Until August 2021
- Paycheck Protection Program Flexibility Act of 2020: Relaxation of Loan Forgiveness Rules
- Net Operating Losses Create Tax Refund Opportunities
- New Bonus Depreciation Rules for Qualified Improvement Property
- Volume Forecasting for Healthcare
- Accounting Considerations Related to COVID-19
- CARES Act Provider Relief
- Healthcare Financial Planning During COVID-19 Crisis
- Navigating Through Uncertain Times
- COVID-19 Telehealth Program
- The CARES Act - Solutions for Healthcare Providers
- Key Tax Implications of the CARES Act
- Families First Coronavirus Response Act
- COVID-19 and JTaylor
- Managing Population Health as Part of a Post-Acute Care Network
- Aligning Incentives with Mission